NLRP3 and diabetic kidney disease: In this study, miR-10a and miR-10b were identified to be predominantly expressed in the kidney and significantly downregulated in podocytes under diabetic conditions, which acted as endogenous inhibitors of the NLRP3 inflammasome in DKD, thereby protecting podocytes against injury in DKD (Ding et al., 2021).